Literature DB >> 23030650

Triplet-primed PCR is more sensitive than southern blotting-long PCR for the diagnosis of myotonic dystrophy type1.

Maria Addis1, Marianna Serrenti, Cristiana Meloni, Milena Cau, Maria Antonietta Melis.   

Abstract

Genetic testing of myotonic dystrophy type 1 (DM1) is very important because it enables the diagnosis and indicates the severity of the disease. Mutation analysis is based on the detection of the number of CTG triplets in the 3' untranslated region of the myotonic dystrophy protein kinase (DMPK) gene. Sometimes it could be complicated by the presence of different patterns of repeat interruptions in the 5' and 3' ends of the expanded alleles recently described in about 3% to 5% of patients. To make molecular diagnosis easier and faster, the use of triplet-primed PCR (TP-PCR) for the detection of expansions in DM1 and other dynamic mutation diseases was proposed. Here we present the results of a retrospective study performed by TP-PCR on 100 subjects previously analyzed by Southern blotting-long PCR.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 23030650     DOI: 10.1089/gtmb.2012.0218

Source DB:  PubMed          Journal:  Genet Test Mol Biomarkers        ISSN: 1945-0257


  8 in total

1.  Identification and characterization of 5' CCG interruptions in complex DMPK expanded alleles.

Authors:  Annalisa Botta; Giulia Rossi; Marzia Marcaurelio; Luana Fontana; Maria Rosaria D'Apice; Francesco Brancati; Roberto Massa; Darren G Monckton; Federica Sangiuolo; Giuseppe Novelli
Journal:  Eur J Hum Genet       Date:  2016-11-23       Impact factor: 4.246

2.  Clinical, pathological and genetic characteristics of a pedigree with myotonic dystrophy type 1.

Authors:  Qing Liu; Yu-Fei Zheng; Yan-Ping Zhu; Shi-Qing Ling; Wei-Rong Li
Journal:  Exp Ther Med       Date:  2015-09-09       Impact factor: 2.447

3.  Simple Repeat-Primed PCR Analysis of the Myotonic Dystrophy Type 1 Gene in a Clinical Diagnostics Environment.

Authors:  Philippa A Dryland; Elaine Doherty; Jennifer M Love; Donald R Love
Journal:  J Neurodegener Dis       Date:  2013-11-11

4.  Assessment of Premutation in Myotonic Dystrophy Type 1 Affected Family Members by TP-PCR and Genetic Counseling.

Authors:  Ashok Kumar; Sarita Agarwal; Sunil Pradhan
Journal:  Case Rep Med       Date:  2014-02-23

5.  Ultrasonography of abdominal muscles: Differential diagnosis of late-onset Pompe disease and myotonic dystrophy type 1.

Authors:  Pei-Chen Hsieh; Chun-Wei Chang; Long-Sun Ro; Chin-Chang Huang; Jia-En Chi; Hung-Chou Kuo
Journal:  Front Neurol       Date:  2022-09-06       Impact factor: 4.086

6.  Characterization of full-length CNBP expanded alleles in myotonic dystrophy type 2 patients by Cas9-mediated enrichment and nanopore sequencing.

Authors:  Massimiliano Alfano; Luca De Antoni; Federica Centofanti; Virginia Veronica Visconti; Simone Maestri; Chiara Degli Esposti; Roberto Massa; Maria Rosaria D'Apice; Giuseppe Novelli; Massimo Delledonne; Annalisa Botta; Marzia Rossato
Journal:  Elife       Date:  2022-08-26       Impact factor: 8.713

7.  Robust Preimplantation Genetic Testing of Huntington Disease by Combined Triplet-Primed PCR Analysis of the HTT CAG Repeat and Multi-Microsatellite Haplotyping.

Authors:  Mingjue Zhao; Felicia Siew Hong Cheah; Arnold Sia Chye Tan; Mulias Lian; Gui Ping Phang; Anupriya Agarwal; Samuel S Chong
Journal:  Sci Rep       Date:  2019-11-11       Impact factor: 4.379

8.  Robust Detection of Somatic Mosaicism and Repeat Interruptions by Long-Read Targeted Sequencing in Myotonic Dystrophy Type 1.

Authors:  Antoine Mangin; Laure de Pontual; Yu-Chih Tsai; Laetitia Monteil; Mathilde Nizon; Pierre Boisseau; Sandra Mercier; Janet Ziegle; John Harting; Cheryl Heiner; Geneviève Gourdon; Stéphanie Tomé
Journal:  Int J Mol Sci       Date:  2021-03-05       Impact factor: 5.923

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.